DFDBA With or Without Platelet‐Rich Fibrin in Maxillary Sinus Augmentation: A Randomized Split‐Mouth Clinical Trial
Clinical Implant Dentistry and Related Research · 2026-12 · 28 (6)
DOI: 10.1111/cid.70189 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Implant Dentistry and Related Research, online erschienen am 04.11.2026. Verfasst von Erkin Doğan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Marmara University, Istanbul, Türkiye. Hauptthemen laut MEDLINE: Platelet-Rich Fibrin, Sinus Floor Augmentation, Bone Transplantation. Die Arbeit nennt 53 Literaturangaben.
Abstract (Originalsprache)
Objectives
To compare histologic and histomorphometric outcomes after bilateral lateral maxillary sinus augmentation with demineralized freeze‐dried bone allograft (DFDBA) alone versus DFDBA combined with platelet‐rich fibrin (PRF), and to report 1‐year prosthetic follow‐up of the restored implants. Materials and Methods This randomized split‐mouth clinical trial included subjects requiring bilateral lateral maxillary sinus augmentation before implant placement. In each subject, one sinus was randomly assigned to DFDBA alone and the contralateral sinus to DFDBA combined with leukocyte‐ and platelet‐rich fibrin (L‐PRF) and injectable PRF (i‐PRF). Bone biopsy specimens were harvested at the clinically relevant 6‐month implant placement time point. The primary outcome was newly formed bone. Secondary histomorphometric outcomes were residual graft material, connective tissue, and fibrosis; inflammation and necrosis were assessed histologically. Clinical and radiographic prosthetic follow‐up was performed 1 year after definitive prosthetic loading. Paired comparisons were performed using the Wilcoxon signed‐rank test.
Results
Of 24 enrolled subjects, 21 completed follow‐up and contributed 42 sinus sites to the paired analysis. Median newly formed bone was 48.72% (IQR, 33.33%–63.33%) on the PRF side and 45.76% (IQR, 37.14%–54.90%) on the non‐PRF side ( p = 0.5). Residual graft material was 6.74% versus 4.23% ( p = 0.2), connective tissue was 31.48% versus 36.92% ( p = 0.016), and fibrosis was 3.42% versus 2.56% ( p > 0.9). No inflammation or necrosis was observed. Following replacement of one implant that failed before prosthetic loading, all definitively restored implants remained functional during the 1‐year prosthetic follow‐up. Clinical and radiographic follow‐up was uneventful, and no biologic or prosthetic complications requiring intervention were observed.
Conclusions
Adding PRF to DFDBA did not significantly increase newly formed bone at the 6‐month implant placement time point. The lower connective tissue proportion on the PRF side may suggest altered tissue maturation; however, this secondary finding should be interpreted cautiously. Definitively restored implants showed 100% prosthetic survival during 1‐year follow‐up. Trial Registration ClinicalTrials.gov Identifier: NCT07348198; https://clinicaltrials.gov/study/NCT07348198 . This clinical trial was not registered prior to participant recruitment and randomization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Marmara University, Istanbul, Türkiye.
- Department of Oral and Maxillofacial Surgery, Ersoy Health Group, Istanbul, Türkiye.
- Department of Pathology, Başakşehir Çam and Sakura City Hospital, Istanbul, Türkiye.
ORCID-Profile: Erkin Doğan, Onur Gönül, İbrahim Murat Afat, Edip Eren Kadıkıran, Cem Berk Türk, Alpay Demir
Zitieren
APA
Doğan, E., Gönül, O., Afat, İ. M., Kadıkıran, E. E., Türk, C. B., & Demir, A. (2026). DFDBA With or Without Platelet‐Rich Fibrin in Maxillary Sinus Augmentation: A Randomized Split‐Mouth Clinical Trial. Clinical Implant Dentistry and Related Research, 28(6). https://doi.org/10.1111/cid.70189
Vancouver
Doğan E, Gönül O, Afat İM, Kadıkıran EE, Türk CB, Demir A. DFDBA With or Without Platelet‐Rich Fibrin in Maxillary Sinus Augmentation: A Randomized Split‐Mouth Clinical Trial. Clinical Implant Dentistry and Related Research. 2026;28(6). doi:10.1111/cid.70189
BibTeX
@article{Doan2026,
author = {Doğan, Erkin and Gönül, Onur and Afat, İbrahim Murat and Kadıkıran, Edip Eren and Türk, Cem Berk and Demir, Alpay},
title = {DFDBA With or Without Platelet‐Rich Fibrin in Maxillary Sinus Augmentation: A Randomized Split‐Mouth Clinical Trial},
journal = {Clinical Implant Dentistry and Related Research},
year = {2026},
volume = {28},
number = {6},
doi = {10.1111/cid.70189}
}
EUVIMED